Breaking News Instant updates and real-time market news.

HSGX

Histogenics

$1.52

-0.02 (-1.30%)

16:11
01/11/17
01/11
16:11
01/11/17
16:11

Histogenics announces publication of data from NeoCart trials

Histogenics announced the online publication in the January 2017 issue of the American Journal of Sports Medicine of a peer-reviewed publication entitled Magnetic Resonance Imaging Characterization and Clinical Outcomes After NeoCart Surgical Therapy as a Primary Reparative Treatment for Knee Cartilage Injuries. The lead investigator is Dr. Dennis Crawford MD, PhD with support from other investigators including Devon E. Anderson, PhD, Riley J. Williams III, MD, Thomas M. DeBerardino, MD, Dean C. Taylor, MD, C. Benjamin Ma, MD, and Marie S. Kane, MS. The publication analyzes magnetic resonance imaging (MRI) data through 60 months follow up from the Phase 1 and 2 clinical trials of NeoCart for the repair of articular cartilage injuries in the knee. "We are very pleased with the results of the clinical trials conducted to date and want to thank our investigators and patients for their participation. We believe this is an area in need of a better alternative for patients who are seeking new options to repair cartilage defects that potentially offer both a more rapid recovery and durable response over time with fewer repeat surgeries," stated Gloria Matthews, Chief Medical Officer of Histogenics. "We believe the MRI data, while limited in the number of patients, provide additional confirmatory evidence of previously reported clinical efficacy outcomes, and demonstrate the potential benefits to patients with cartilage defects. We are looking forward to the availability of additional data from the continuing development of this promising treatment alternative," continued Dr. Matthews.The demonstrated rapid maturation of cartilage as evidenced by the MRI data from the Phase 1 and Phase 2 clinical trials is consistent with biomechanical data recently presented by Histogenics and Cornell University that showed that in vitro cartilage constructs, or tissue implants, produced using a process that is designed to mimic that of NeoCart exhibited mechanical properties prior to implantation that were similar to that of native cartilage. These results suggest that the maturation of tissue-engineered cartilage implants, such as NeoCart, leads to improved mechanical properties prior to implantation and may result in a more rapid recovery and return to function for patients suffering from cartilage defects."We believe the data from these two clinical trials are compelling and provide further evidence that NeoCart implants may provide an improved alternative for patients with knee cartilage defects," stated, Dr. Dennis Crawford, Department of Orthopaedics & Rehabilitation, Oregon Health & Science University. "The NeoCart implants appear to improve knee function and quality of life two years after surgery with maintenance through five years," continued Dr. Crawford.

HSGX Histogenics
$1.52

-0.02 (-1.30%)

08/12/16
BTIG
08/12/16
UPGRADE
Target $3.5
BTIG
Buy
Histogenics upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded Histogenics to Buy saying the "goal line is in sight" after the company reported another quarter of "solid patient enrollment rates" for its continued Phase 3 NeoCart trial. The analyst has "strong confidence" the trial will be completed. He has a $3.50 price target for the shares.
12/19/16
HCWC
12/19/16
INITIATION
Target $3.5
HCWC
Buy
Histogenics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Histogenics with a Buy rating and $3.50 price target.

TODAY'S FREE FLY STORIES

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
Peters & Co. hold a conference »

Limited Energy Conference…

ETFC

E-Trade

$36.39

0.15 (0.41%)

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
E*Trade to hold education day »

E*Trade's Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

AMGN

Amgen

$154.67

0.87 (0.57%)

, BAYRY

Bayer

$109.31

0.98 (0.90%)

04:55
01/21/17
01/21
04:55
01/21/17
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2017 Gastrointestinal…

AMGN

Amgen

$154.67

0.87 (0.57%)

BAYRY

Bayer

$109.31

0.98 (0.90%)

BMY

Bristol-Myers

$49.23

-6.26 (-11.28%)

CCXI

ChemoCentryx

$7.56

-0.32 (-4.06%)

CELG

Celgene

$112.66

-0.96 (-0.84%)

DNA

Bought by RHHBY

EXEL

Exelixis

$17.92

0.02 (0.11%)

HALO

Halozyme

$11.50

0.42 (3.79%)

LXRX

Lexicon

$13.84

-0.19 (-1.35%)

MACK

Merrimack

$3.00

-0.05 (-1.64%)

MRK

Merck

$62.53

2.2 (3.65%)

NVS

Novartis

$70.65

0.22 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 26

    Jan

  • 26

    Jan

  • 01

    Feb

  • 02

    Feb

  • 12

    Feb

  • 16

    Feb

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

  • 28

    Feb

  • 02

    Mar

  • 08

    Mar

  • 15

    Mar

  • 10

    May

  • 27

    May

  • 19

    Jul

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

, COH

Coach

$35.31

0.21 (0.60%)

18:54
01/20/17
01/20
18:54
01/20/17
18:54
Periodicals
Kate Spade draws interest from Coach, Michael Kors, Bloomberg reports »

Kate Spade (KATE) is…

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

COH

Coach

$35.31

0.21 (0.60%)

KORS

Michael Kors

$42.46

0.43 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

CTIC

CTI BioPharma

$4.97

-0.1 (-1.97%)

18:14
01/20/17
01/20
18:14
01/20/17
18:14
Hot Stocks
CTI BioPharma regains compliance with Nasdaq Listing Rule »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$40.46

0.06 (0.15%)

18:06
01/20/17
01/20
18:06
01/20/17
18:06
Hot Stocks
Abbott sponsored study shows SCS therapy can reduce, stabilize opioid use »

New research has found…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 21

    Feb

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

18:02
01/20/17
01/20
18:02
01/20/17
18:02
Periodicals
Wal-Mart begins corporate job cuts at headquarters, WSJ reports »

Wal-Mart has started on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$35.31

0.21 (0.60%)

, KORS

Michael Kors

$42.46

0.43 (1.02%)

17:46
01/20/17
01/20
17:46
01/20/17
17:46
Periodicals
Breaking Periodicals news story on Coach, Michael Kors, Kate Spade »

Coach, Michael Kors to…

COH

Coach

$35.31

0.21 (0.60%)

KORS

Michael Kors

$42.46

0.43 (1.02%)

KATE

Kate Spade

$17.76

-0.07 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

BELFB

Bel Fuse

$31.80

0.2 (0.63%)

17:33
01/20/17
01/20
17:33
01/20/17
17:33
Hot Stocks
Gabelli reports 23.15% stake in Bel Fuse »

GAMCO, pursuant to Rule…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$63.65

0.75 (1.19%)

17:32
01/20/17
01/20
17:32
01/20/17
17:32
Hot Stocks
ResMed, BMC, 3B Medical settle global litigation »

ResMed, BMC, and 3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$3.50

0.05 (1.45%)

17:27
01/20/17
01/20
17:27
01/20/17
17:27
Hot Stocks
Breaking Hot Stocks news story on Northern Oil and Gas »

Elliott Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTE

Baytex Energy

$4.06

0.01 (0.25%)

17:12
01/20/17
01/20
17:12
01/20/17
17:12
Hot Stocks
Baytex Energy closes Peace River acquisition »

Baytex Energy closed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FGEN

FibroGen

$25.60

1 (4.07%)

17:09
01/20/17
01/20
17:09
01/20/17
17:09
Hot Stocks
FibroGen 'encouraged' by updated pamrevlumab clinical data »

FibroGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$18.86

-0.199 (-1.04%)

17:03
01/20/17
01/20
17:03
01/20/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Innovative Industrial Properties »

Alan D. Gold raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITE

SiteOne Landscape

$37.26

0.41 (1.11%)

17:03
01/20/17
01/20
17:03
01/20/17
17:03
Hot Stocks
SiteOne Landscape acquires Aspen Valley Landscape Supply »

SiteOne Landscape…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCB

Itau Corpbanca

$12.55

-0.08 (-0.63%)

17:01
01/20/17
01/20
17:01
01/20/17
17:01
Hot Stocks
Itau Corpbanca files Material Event Notice »

Itau Corpbanca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$232.20

0.79 (0.34%)

16:50
01/20/17
01/20
16:50
01/20/17
16:50
Hot Stocks
Goldman Sachs chief accounting officer Smith to become global head of compliance »

Goldman Sachs said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$6.65

0.1 (1.53%)

16:47
01/20/17
01/20
16:47
01/20/17
16:47
Hot Stocks
DAVIDsTEA announces two leadership departures »

DAVIDsTEA's Chief HR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

, BAYRY

Bayer

$109.31

0.98 (0.90%)

16:47
01/20/17
01/20
16:47
01/20/17
16:47
General news
On The Fly: Stocks end week mixed as Trump takes office »

Stocks ended the week…

WMT

Wal-Mart

$67.18

-0.44 (-0.65%)

BAYRY

Bayer

$109.31

0.98 (0.90%)

GM

General Motors

$37.01

-0.29 (-0.78%)

NFLX

Netflix

$138.60

0.19 (0.14%)

XOM

Exxon Mobil

$85.89

1.16 (1.37%)

JCP

J.C. Penney

$6.85

0.16 (2.39%)

NKE

Nike

$53.20

0.27 (0.51%)

CSX

CSX

$44.33

-1.18 (-2.59%)

CP

Canadian Pacific

$150.99

0.68 (0.45%)

FWP

Forward Pharma

$30.76

2.01 (6.99%)

CWEI

Clayton Williams

$146.85

-1.18 (-0.80%)

NBL

Noble Energy

$40.21

-0.06 (-0.15%)

RAI

Reynolds American

$58.71

0.13 (0.22%)

BTI

British American Tobacco

$117.30

0.54 (0.46%)

LLY

Eli Lilly

$76.81

-0.03 (-0.04%)

CLCD

CoLucid Pharmaceuticals

$46.25

-0.05 (-0.11%)

WBA

Walgreens Boots Alliance

$81.72

-1.77 (-2.12%)

RAD

Rite Aid

$7.46

-1.14 (-13.26%)

TGT

Target

$64.10

-1.29 (-1.97%)

GIMO

Gigamon

$34.20

1.35 (4.11%)

PSO

Pearson

FAST

Fastenal

$51.24

0.69 (1.37%)

CHKP

Check Point

$97.79

1.45 (1.51%)

PG

Procter & Gamble

$87.45

2.75 (3.25%)

IBM

IBM

$170.55

3.74 (2.24%)

SWKS

Skyworks

$88.67

10.21 (13.01%)

MS

Morgan Stanley

$42.59

0.14 (0.33%)

PRGS

Progress Software

$28.18

0.16 (0.57%)

CMA

Comerica

$66.96

0.65 (0.98%)

UNH

UnitedHealth

$158.66

-0.04 (-0.03%)

GS

Goldman Sachs

$232.20

0.79 (0.34%)

C

Citi

$56.11

-0.55 (-0.97%)

RCII

Rent-A-Center

$8.40

0.09 (1.08%)

GE

General Electric

$30.53

-0.68 (-2.18%)

AXP

American Express

$76.20

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 20

    Jan

  • 24

    Jan

  • 26

    Jan

  • 26

    Jan

  • 31

    Jan

  • 02

    Feb

  • 07

    Feb

  • 13

    Feb

  • 14

    Feb

  • 14

    Feb

  • 16

    Feb

  • 20

    Feb

  • 21

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 19

    Apr

TSO

Tesoro

$80.48

-0.08 (-0.10%)

16:42
01/20/17
01/20
16:42
01/20/17
16:42
Hot Stocks
Breaking Hot Stocks news story on Tesoro »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$42.59

0.14 (0.33%)

, OIBR

Oi S.A.

16:40
01/20/17
01/20
16:40
01/20/17
16:40
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Oi S.A.  »

Morgan Stanley reports 5%…

MS

Morgan Stanley

$42.59

0.14 (0.33%)

OIBR

Oi S.A.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMH

UMH Properties

16:36
01/20/17
01/20
16:36
01/20/17
16:36
Hot Stocks
UMH Properties closes acquisition of two Ohio communities for about $9.6M »

UMH Properties announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOP

Bioptix

$3.43

0.01 (0.29%)

16:36
01/20/17
01/20
16:36
01/20/17
16:36
Hot Stocks
Bioptix announces workforce reductions »

Bioptix adopted a plan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$115.60

0.02 (0.02%)

16:35
01/20/17
01/20
16:35
01/20/17
16:35
Hot Stocks
Court rejects attempt to enforce Ecuadorian judgment against Chevron unit »

A Canadian court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 23

    Mar

MIME

Mimecast

$21.42

-0.95 (-4.25%)

16:34
01/20/17
01/20
16:34
01/20/17
16:34
Syndicate
Breaking Syndicate news story on Mimecast »

Mimecast files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 13

    Feb

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.